New drug targets for the treatment of obesity
AG Powell, CM Apovian… - Clinical pharmacology & …, 2011 - Wiley Online Library
There is a huge void in the current pharmacological treatment options for obesity. This gap is
surprising given the high prevalence and associated costs of obesity. Many factors have …
surprising given the high prevalence and associated costs of obesity. Many factors have …
New drug targets for the treatment of obesity.
AG Powell, CM Apovian, LJ Aronne - Clinical Pharmacology and …, 2011 - europepmc.org
There is a huge void in the current pharmacological treatment options for obesity. This gap is
surprising given the high prevalence and associated costs of obesity. Many factors have …
surprising given the high prevalence and associated costs of obesity. Many factors have …
New drug targets for the treatment of obesity.
AG Powell, CM Apovian, LJ Aronne - 2011 - cabidigitallibrary.org
There is a huge void in the current pharmacological treatment options for obesity. This gap is
surprising given the high prevalence and associated costs of obesity. Many factors have …
surprising given the high prevalence and associated costs of obesity. Many factors have …
New Drug Targets for the Treatment of Obesity.
AG Powell, CM Apovian… - Clinical Pharmacology & …, 2011 - search.ebscohost.com
There is a huge void in the current pharmacological treatment options for obesity. This gap is
surprising given the high prevalence and associated costs of obesity. Many factors have …
surprising given the high prevalence and associated costs of obesity. Many factors have …
[引用][C] New Drug Targets for the Treatment of Obesity
AG POWELL, CM APOVIAN… - Clinical pharmacology …, 2011 - pascal-francis.inist.fr
New Drug Targets for the Treatment of Obesity CNRS Inist Pascal-Francis CNRS Pascal
and Francis Bibliographic Databases Simple search Advanced search Search by …
and Francis Bibliographic Databases Simple search Advanced search Search by …
New drug targets for the treatment of obesity
AG Powell, CM Apovian… - Clinical pharmacology …, 2011 - pubmed.ncbi.nlm.nih.gov
There is a huge void in the current pharmacological treatment options for obesity. This gap is
surprising given the high prevalence and associated costs of obesity. Many factors have …
surprising given the high prevalence and associated costs of obesity. Many factors have …
[PDF][PDF] New Drug Targets for the Treatment of Obesity
AG Powell, CM Apovian, LJ Aronne - CliNiCal pHaRMaCology & …, 2011 - obesitycast.com
There is a huge void in the current pharmacological treatment options for obesity. This gap is
surprising given the high prevalence and associated costs of obesity. Many factors have …
surprising given the high prevalence and associated costs of obesity. Many factors have …